Welcome to our dedicated page for Teradyne SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Teradyne’s filings can feel like a maze of wafer-probe yields, robot backlog figures and segment margin footnotes. If you have ever tried to extract robotics revenue trends or find when executives exercised stock options inside a 300-page report, you know the challenge. Our platform tackles that complexity head-on, turning every Teradyne annual report 10-K simplified and each Teradyne quarterly earnings report 10-Q filing into clear, searchable insights.
Stock Titan’s AI reads each document the moment it hits EDGAR and delivers:
- Teradyne Form 4 insider transactions real-time, so you monitor executive stock moves without waiting.
- Concise notes that make Teradyne 8-K material events explained in plain English.
- Segment breakouts and cash-flow flags highlighted inside every Teradyne earnings report filing analysis.
- Red-lined changes across proxies for quick views of Teradyne proxy statement executive compensation shifts.
Whether you’re understanding Teradyne SEC documents with AI for long-term research or need instant alerts on Teradyne insider trading Form 4 transactions, our coverage spans all forms�10-K, 10-Q, 8-K, S-8 and more. Investors routinely use these insights to compare semiconductor test bookings quarter over quarter, gauge robotics margin expansion, and track Teradyne executive stock transactions Form 4 before earnings. Teradyne SEC filings explained simply mean no more scrolling past dense test-equipment jargon: just the numbers, risks and material disclosures that move the stock.
Reporting person: Gregory Stephen Smith, who serves as President and CEO and a director of Teradyne, Inc. (TER), reported an insider sale on Form 4. The transaction occurred on 08/12/2025 and was reported on a Form 4 signed by an attorney-in-fact on 08/14/2025. The filing shows 554 shares of Teradyne common stock were sold at a price of $106 per share pursuant to a pre-established Rule 10b5-1 sales plan adopted on February 4, 2025. After the reported sale, the filing shows the reporting person beneficially owns 96,992.995 shares directly.
Teradyne's Form 144 reports a proposed sale of 554 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $58,724 and an approximate sale date of 08/12/2025 on NASDAQ. The filing lists total shares outstanding as 159,073,532, indicating the position is very small relative to the company's capitalization. The securities were acquired by restricted stock vesting on 01/27/2025, and the consideration is recorded as compensation.
The notice also records a prior sale of the same 554 shares on 07/30/2025 for $58,574.42. The form includes the standard Rule 144 representation regarding absence of undisclosed material adverse information and a field for Rule 10b5-1 plan adoption if applicable, though no plan adoption date is provided in the filing.
SEC Form 4 � Teradyne, Inc. (TER)
- Director Mercedes Johnson sold 625 common shares on 08/05/2025 at $106 per share.
- The disposition was made pursuant to a Rule 10b5-1 trading plan adopted 02/03/2025, indicating a pre-scheduled, compliance-driven sale.
- Post-transaction ownership: 11,363 shares held directly; an additional 1,876 shares held indirectly through The Mercedes Johnson Trust.
No derivative securities were reported and no other transactions were disclosed. The 625-share sale represents a small fraction of the director’s total holdings; therefore, the filing appears routine with limited immediate investment significance.
Teradyne, Inc. (TER) filed a Form 144 indicating that shareholder Mercedes Johnson plans to sell up to 625 common shares through Fidelity Brokerage on or after 08/05/2025. At the latest reported market price, the sale would total roughly $66,250. The shares originated from a 05/09/2024 restricted-stock vesting transaction and were received as compensation.
Johnson has already sold 1,875 shares for $198,243.75 during the past three months. The proposed sale represents 0.0004 % of TER’s 159,073,532 shares outstanding, suggesting minimal dilution or trading-volume impact. No material adverse information was reported, and the signer affirms compliance with Rule 10b5-1 and other SEC requirements.
Teradyne (TER) Form 4 highlights a modest insider trade. On 07/30/2025 director Mercedes Johnson sold 1,875 shares of common stock at $105.73 per share under a pre-arranged Rule 10b5-1 plan adopted 02/03/2025, realizing about $0.2 million in gross proceeds.
After the sale, Johnson directly owns 11,988 shares and indirectly owns 1,876 shares via The Mercedes Johnson Trust, bringing total beneficial ownership to 13,864 shares. No derivative securities were involved. The indirect position reflects a 06/05/2025 transfer to her trust that was exempt from reporting under Rule 16a-13. The filing shows no other transactions and appears routine.
Teradyne President & CEO Gregory S. Smith filed a Form 4 reporting the sale of 554 common shares on 30 Jul 2025 at an average price of $105.73, yielding proceeds of roughly $58 k. The trade was executed under a Rule 10b5-1 plan adopted 4 Feb 2025, signalling it was pre-scheduled rather than opportunistic.
Following the transaction, Smith directly owns 97,546.995 shares, which already include 98.7673 shares purchased via the Employee Stock Purchase Plan on 30 Jun 2025. No derivative security activity was reported.
The sale represents about 0.6 % of his direct holdings and is immaterial relative to Teradyne’s total shares outstanding, suggesting limited market impact. No additional insider transactions or corporate events were disclosed in this filing.
FAQ
What is the current stock price of Teradyne (TER)?
What is the market cap of Teradyne (TER)?
